Skittish about stocks? The managers of BBH Core Select have carefully constructed a 30-name portfolio that has been more stable than the market.
Six good funds are hit with outflows, but three small good funds are seeing inflows.
The five biotech ETFs have very different portfolios with markedly different performance.
These funds follow the Oracle of Omaha in buying and holding quality businesses.
IShares pursues a new ETF strategy and branding initiative with a core series of funds for buy-and-hold investors, BBH Core Select nears capacity, and Vanguard rolls out a new TIPS product.
Some managers have boosted their investment in their funds. I name names.